Spots Global Cancer Trial Database for tirapazamine
Every month we try and update this database with for tirapazamine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| TRACE: Tirapazamine-Radiation And Cisplatin Evaluation | NCT00174837 | Head and Neck S... | Tirapazamine Cisplatin | 18 Years - | Sanofi | |
| Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer | NCT02174549 | Hepatocellular ... Gastrointestina... Neuroendocrine ... | Tirapazamine Conventional Tr... | 20 Years - 99 Years | Teclison Ltd. | |
| S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer | NCT00006487 | Lung Cancer | cisplatin etoposide tirapazamine radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | NCT00033410 | Lung Cancer | carboplatin paclitaxel tirapazamine radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer | NCT00003369 | Cervical Cancer | cisplatin tirapazamine | 18 Years - | SWOG Cancer Research Network | |
| Study of Tumour Response to Tirapazamine During Treatment of Cervical Cancer | NCT00493376 | Cervix Cancer | Cervical tissue... Biopsy: Measure... Biopsy: Immunoh... Measurement of ... | 18 Years - | British Columbia Cancer Agency | |
| S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer | NCT00003369 | Cervical Cancer | cisplatin tirapazamine | 18 Years - | SWOG Cancer Research Network | |
| TATE Versus TACE in Intermediate Stage HCC | NCT03145558 | Carcinoma, Hepa... | Tirapazamine Doxorubicin | 18 Years - 85 Years | Teclison Ltd. | |
| TATE Versus TACE in Intermediate Stage HCC | NCT03145558 | Carcinoma, Hepa... | Tirapazamine Doxorubicin | 18 Years - 85 Years | Teclison Ltd. | |
| Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | NCT00066742 | Limited Stage S... | tirapazamine cisplatin etoposide radiation thera... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| TATE and Pembrolizumab (MK3475) in mCRC and NSCLC | NCT04701476 | Colorectal Canc... | TATE and pembro... TAS-102 pill Regorafenib Pil... | 18 Years - | Teclison Ltd. | |
| S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer | NCT00006487 | Lung Cancer | cisplatin etoposide tirapazamine radiation thera... | 18 Years - | SWOG Cancer Research Network | |
| Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | NCT00002774 | Squamous Neck C... | Tirapazamine Cisplatin 5-fluorouracil Radiotherapy (R... | 17 Years - | Stanford University | |
| Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors | NCT00003288 | Unspecified Chi... | filgrastim cyclophosphamid... tirapazamine | - 21 Years | National Cancer Institute (NCI) | |
| Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer | NCT00262821 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage IB Cervic... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage IVA Cervi... | cisplatin tirapazamine | 18 Years - | National Cancer Institute (NCI) | |
| Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | NCT00025363 | Alveolar Childh... Embryonal Child... Embryonal-botry... Previously Trea... Recurrent Child... | vincristine sul... irinotecan hydr... cyclophosphamid... doxorubicin hyd... ifosfamide etoposide tirapazamine filgrastim sargramostim pharmacological... pharmacogenomic... laboratory biom... | - 20 Years | National Cancer Institute (NCI) | |
| Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer | NCT02174549 | Hepatocellular ... Gastrointestina... Neuroendocrine ... | Tirapazamine Conventional Tr... | 20 Years - 99 Years | Teclison Ltd. | |
| Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00017459 | Lung Cancer | cisplatin tirapazamine vinorelbine tar... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | NCT00033410 | Lung Cancer | carboplatin paclitaxel tirapazamine radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors | NCT00005078 | Unspecified Adu... | carboplatin paclitaxel tirapazamine | 18 Years - | City of Hope Medical Center | |
| Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | NCT00025363 | Alveolar Childh... Embryonal Child... Embryonal-botry... Previously Trea... Recurrent Child... | vincristine sul... irinotecan hydr... cyclophosphamid... doxorubicin hyd... ifosfamide etoposide tirapazamine filgrastim sargramostim pharmacological... pharmacogenomic... laboratory biom... | - 20 Years | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
